A just released American Heart Association scientific statement on the management of hyperglycemia in patients with ACS is refreshingly circumspect and free of dogma.
Strong pathophysiologic rationale supports aggressive glycemic control in patients with ACS but questions remain about the proper targets and the hazards of hypoglycemia.
The AHA report contains a nice evidence summary and concludes that while hyperglycemia should not be ignored the jury is still out concerning the appropriate glucose target. The report provides some “soft” recommendations with the disclaimer that they are for general reference only and points out that evidence does not support glycemic control as a quality measure during ACS hospitalization.
This is a must read, must bookmark document for physicians practicing hospital medicine.